New study on burden of cancer in the Middle East and Africa
By annette
A new study by IHE in Value in Health Regional Issues estimates the disease burden and economic burden of cancer in the Middle East and Africa. Read more
By annette
A new study by IHE in Value in Health Regional Issues estimates the disease burden and economic burden of cancer in the Middle East and Africa. Read more
By annette
The Swedish Institute for Health Economics welcomes Hedda Carlsson and Bardh Manxhuka who joined our team in June and they both work as research analyst at the Lund office.
By annette
On June 8th, IHE’s Thomas Hofmarcher participated in a webinar organized by the Financial Times to mark the official launch of IHE Report 2023:2. The report shows that triple-negative breast cancer (TNBC) is the most difficult-to-treat subtype of breast cancer. It accounts for about 10–20% of newly diagnosed breast cancer cases but is responsible for …
By annette
We are happy to announce that Jenni Nordborg – Director of International Affairs at Lif – The research-based pharmaceutical industri – joins our Board of Directors Read more about Jenni Nordborg
By annette
In this IHE report the author Ulf Persson, senior advisor at IHE, has identified a number of conditions which lead to the fact that today’s methods of valuing medicines hardly lead us to a satisfactory understanding of the value of orphan medicines. The insurance value, the value of hope and process-related benefits are not included. …
By annette
Michael Willis from IHE will participate in two workshops at SMDM-Society for Medical Decision Making, May 21-23 in Berlin. Issue Panel 1C: Proving health economics models are valid – why, how and who? Chair: Talitha Feenstra (National Institute for Public Health and the Environment (RIVM), Netherlands) Panelists: Amanda Adler, University of Oxford, UK Xavier Pouwels, …
By annette
New IHE Report about challenges and opportunities to improve the care of women with triple-negative breast cancer in Asia-Pacific. Read more and download the report
By annette
IHE participates at the conference with a poster presentation on the importance of considering price metrics and market dynamics in US economic evaluation, using the case of SGLT-2 inhibitors in the treatment of T2D. Michael Willis from IHE will also moderate a workshop, “Addressing Heterogeneity in Comparative Economic Analysis in the Decentralized US Setting: Are …
By annette
The Swedish Institute for Health Economics participates at the 11th Asia-Pacific Breast Cancer Summit 2023 on May 4-6, 2023 in Singapore. Thomas Hofmarcher will present findings of an upcoming policy report on triple-negative breast cancer (TNBC) in the Asia-Pacific region. He will highlight the health-economic impact of TNBC on patients and society as well as …
By annette
PRIME-ROSE is a precision cancer medicine trial network and implementation initiative.The PRIME-ROSE vision is access to affordable precision cancer medicine that prolongs life at the best quality possible for all cancer patients. Read more